Company intelligence / Profile preview

Gearbox Biosciences

Ownership: Private
Development stage: Commercial

Overview

The company has developed a novel technology for antibiotic-free protein production in E. coli that also doesn't require inducers like IPTG. They have issued a license to their first customer and are working on developing the technology for small-scale production.

Therapeutic areas: Endocrinology
Modalities: Recombinant proteins
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Gearbox Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gearbox Biosciences.

Explore the full profile